Antibody treatment of RelBΔDC mice did not completely deplete Foxp3+ Treg cells in the peripheral blood but rather temporarily reduced their frequency to control levels during the primary infection and increased again after finishing the treatment at day 28 post primary infection (Supplementary Fig. 6a, b). The gene discussed is FOXP3; the disease is infection.